Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 study - Top-Institutions - MDSpire

Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 study

  • By

  • Neeltje Steeghs

  • Carlos Gomez-Roca

  • Iphigénie Korakis

  • Eelke Gort

  • Hilde De Winter

  • Nina Stojcheva

  • Vaia Stavropoulou

  • Jennifer Krieg

  • Paul Baverel

  • Elena Fernandez

  • Ana Maria Florescu

  • Lea Hoenig

  • Michael Peter Sanderson

  • Vladimir Kirkin

  • Philippe Legenne

  • Philippe Alexandre Cassier

  • May 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Moffitt Cancer Center
    Moffitt Cancer Center

    Tampa, Florida

    Key Differentiators

    • Oncology

  • #3

    University of Iowa
    University of Iowa

    Iowa City, Iowa

    Key Differentiators

    • Oncology

  • #4

    University Hospital Essen
    University Hospital Essen

    Essen, North Rhine-Westphalia

    Key Differentiators

    • Oncology

  • #5

    Johns Hopkins Sidney Kimmel Cancer Center
    Johns Hopkins Sidney Kimmel Cancer Center

    Baltimore, Maryland

    Key Differentiators

    • Oncology

Original Source(s)

Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 study

  • by Neeltje Steeghs, Carlos Gomez-Roca, Iphigénie Korakis, Eelke Gort, Hilde De Winter, Nina Stojcheva, Vaia Stavropoulou, Jennifer Krieg, Paul Baverel, Elena Fernandez, Ana Maria Florescu, Lea Hoenig, Michael Peter Sanderson, Vladimir Kirkin, Philippe Legenne, Philippe Alexandre Cassier

  • May 1, 2026

Related Content

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report

High-grade astrocytoma with piloid features: a case report of comprehensive management

FEBAIR microsurgical principles in meningiomas and recurrence: a long-term follow-up series